Connect your AI

ResMed RMD FX & Other Adjustments

Discontinued — last reported Q2 '22

FX & Other Adjustments at other companies

LivaNovaLIVN

$10.71M+230%

MedtronicMDT

——

Baxter InternationalBAX

——

Segments

By segment

Residential Care Software-$16.11M-149%

Sleep And Breathing Health-$4.06M-138%

Other financials

Income statement

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

Market cap$29.05B-22.6%

Enterprise value$28.5B-23.3%

P/E19.1×-7.7×

P/S5.3×-2.0×

Profitability

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: ResMed’s 10-Q, filed January 28, 2022, on SEC EDGAR. View the filing →

Ask your AI about ResMed's fx & other adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ResMed's FX & other adjustments?: ResMed (RMD) reported FX & other adjustments of -$4.08M in Q4 2021.